相关实验视频

Updated: Jun 4, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

针对性循环脂质介质和免疫细胞基因转录在ST升高心肌梗塞后

Dae Hyun Lee^1,2, Gunjan Upadhyay^1,2, Siddabasave Gowda B Gowda^3,4

¹Division of Cardiovascular Sciences, Heart Institute, Department of Internal Medicine, Morsani College of Medicine, University of South Florida Tampa, Florida, USA.

American journal of physiology. Heart and circulatory physiology

|December 20, 2024

概括

专门的亲解决媒介 (SPMs) 和亲炎性脂质媒介 (PIMs) 的动态在接受皮肤冠状动脉干预 (PCI) 的ST升高心肌梗塞 (STEMI) 患者中进行了研究. 结果显示同时发生炎症和解消,这表明PCI之前加强了内源性修复,以更好地治疗心肌梗塞 (MI).

科学领域:

心血管医学心血管医学
利皮多米克 (Lipidomics) 是一种消化剂.
炎症和解决生物学

背景情况:

残留炎症是动脉样硬化进展到心肌梗塞 (MI) 的关键驱动因素.
来自多不和脂肪酸的专用亲溶解媒介 (SPMs) 促进MI后的恢复,与亲炎性脂质媒介 (PIMs) 不同.
在ST升高心肌梗塞 (STEMI) 和穿皮冠状动脉干预 (PCI) 后,脂质介质和基因转录的早期动态变化仍然不明.

研究的目的:

评估在接受PCI的STEMI患者中循环脂质介质和脂质通路转录的早期动态变化.
在STEMI中调查PCI后的炎症和分离信号的时间动力学.

主要方法:

一项前性观察性研究,包括10名STEMI患者和6名对照患者.
分析了血脂介质概况 (向性氧脂) 和全血炎症相关的转录表达.
样本在基线 (PCI前) 和PCI后2小时和24小时收集.

主要成果:

与对照人群相比,STEMI患者的临床水平显示了更高的林诺酸和多可萨氨酸.
较高的基线PIMs (例如,PGE2) 在PCI后下降,而一些SPM水平仍然很高,这表明同时发生炎症和消失.
时间动力学表明,炎症启动和解消过程同时作为STEMI的内源性修复机制开始.

结论:

在STEMI患者PCI后的脂质介质早期变化突出显示了同时发生的炎症和溶解反应.
这些发现支持在STEMI期间活跃的内源性修复机制的概念.
旨在在PCI之前增强内源性SPM的治疗策略需要考虑改善MI治疗结果.

关键词:

这是一种炎症炎症炎症炎症.脂质调解剂脂质调解剂心肌梗塞的心脏病发作炎症的解决方法炎症的解决方法专门支持解决问题的调解员.

更多相关视频

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...